PubRank

Kauko Saarilahti

Author PubWeight™ 15.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Management and outcome of salivary duct carcinoma in major salivary glands. Eur Arch Otorhinolaryngol 2012 1.06
2 Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. Int J Radiat Oncol Biol Phys 2011 1.01
3 Adaptive radiotherapy in muscle invasive urinary bladder cancer--an effective method to reduce the irradiated bowel volume. Radiother Oncol 2011 0.91
4 Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer. Radiother Oncol 2008 0.89
5 Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 2007 0.86
6 Commissioning of MRI-only based treatment planning procedure for external beam radiotherapy of prostate. Magn Reson Med 2012 0.85
7 L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study. Int J Radiat Oncol Biol Phys 2011 0.85
8 Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin. Radiother Oncol 2010 0.84
9 The developing management of esthesioneuroblastoma: a single institution experience. Eur Arch Otorhinolaryngol 2011 0.83
10 Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer. Acta Oncol 2011 0.82
11 TGFbeta1 genetic polymorphism is associated with survival in head and neck squamous cell carcinoma independent of the severity of chemoradiotherapy induced mucositis. Oral Oncol 2010 0.81
12 Erratum to "Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer" [Radiother. Oncol. 78 (2006) 270-275]. Radiother Oncol 2006 0.81
13 Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival. Acta Oncol 2011 0.81
14 High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis. Head Neck 2012 0.80
15 Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands. Radiother Oncol 2009 0.80
16 Boron neutron capture therapy (BNCT) followed by intensity modulated chemoradiotherapy as primary treatment of large head and neck cancer with intracranial involvement. Radiother Oncol 2011 0.78
17 Intensity-modulated radiotherapy in definitive oncological treatment of hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2014 0.78
18 NRS-2002 for pre-treatment nutritional risk screening and nutritional status assessment in head and neck cancer patients. Support Care Cancer 2014 0.78
19 Implementation of adaptive radiation therapy for urinary bladder carcinoma: imaging, planning and image guidance. Acta Oncol 2013 0.77
20 [Boron neutron capture therapy (BNCT) as cancer treatment]. Duodecim 2011 0.77
21 Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma. Acta Otolaryngol 2012 0.76
22 [Current issues in the treatment of pharyngeal cancer]. Duodecim 2011 0.75
23 [Therapeutic results in oral cancer--what has been learned?]. Duodecim 2011 0.75
24 Increased incidence of oropharyngeal cancer and p16 expression. Acta Otolaryngol 2011 0.75
25 Pattern of recurrent disease in major salivary gland adenocystic carcinoma. Virchows Arch 2015 0.75